US Stock MarketDetailed Quotes

MDxHealth (MDXH)

Watchlist
  • 0.5430
  • -0.0187-3.33%
Close Jun 18 16:00 ET
  • 0.5689
  • +0.0259+4.77%
Post 16:18 ET
27.89MMarket Cap-0.84P/E (TTM)

MDxHealth (MDXH) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
12.74%27.39M
19.80%107.88M
19.43%29.55M
17.65%27.43M
20.06%26.61M
22.48%24.29M
28.29%90.05M
27.53%24.74M
20.50%23.32M
32.33%22.16M
Operating revenue
12.74%27.39M
19.80%107.88M
19.43%29.55M
17.65%27.43M
20.16%26.59M
22.48%24.29M
28.29%90.05M
27.53%24.74M
20.50%23.32M
32.95%22.13M
Cost of revenue
22.58%10.77M
9.55%38.24M
17.74%10.86M
5.71%9.56M
1.86%9.04M
13.09%8.79M
32.91%34.91M
37.09%9.22M
33.03%9.04M
31.35%8.87M
Gross profit
7.16%16.61M
26.28%69.63M
20.43%18.69M
25.22%17.88M
32.22%17.57M
28.53%15.5M
25.52%55.14M
22.46%15.52M
13.72%14.28M
32.99%13.29M
Operating expense
19.04%23.92M
7.37%85M
28.21%24.91M
0.74%20.52M
-5.90%19.48M
7.63%20.09M
12.03%79.17M
5.66%19.43M
19.01%20.37M
16.75%20.7M
Selling and administrative expenses
30.98%20.52M
8.72%66.75M
28.10%16.88M
10.35%18.05M
-1.93%16.16M
1.79%15.66M
5.31%61.4M
-9.66%13.18M
13.25%16.35M
9.82%16.48M
-Selling and marketing expense
25.82%12.36M
20.66%7.77M
9.18%-22.56M
-0.29%10.59M
-6.69%9.92M
-2.06%9.82M
-12.53%6.44M
-23.78%-24.84M
17.21%10.62M
14.68%10.63M
-General and administrative expense
39.66%8.16M
7.32%58.98M
3.75%39.44M
30.06%7.46M
6.73%6.24M
9.01%5.84M
7.89%54.95M
9.70%38.02M
6.58%5.74M
1.95%5.84M
Research and development costs
-14.61%2.13M
-1.91%10.35M
17.54%3.28M
-25.58%2.01M
-11.57%2.57M
15.48%2.5M
65.50%10.55M
52.43%2.79M
73.22%2.7M
73.42%2.9M
Depreciation amortization depletion
-4.31%1.27M
8.81%7.93M
7.48%3.99M
-2.26%1.3M
17.54%1.32M
17.51%1.32M
19.15%7.29M
35.03%3.72M
17.64%1.33M
0.72%1.12M
-Depreciation and amortization
-4.31%1.27M
8.81%7.93M
7.48%3.99M
-2.26%1.3M
17.54%1.32M
17.51%1.32M
19.15%7.29M
35.03%3.72M
17.64%1.33M
0.72%1.12M
Other operating expenses
-99.67%2K
56.34%-31K
397.64%756K
-7,481.82%-834K
-376.35%-561K
6,855.56%608K
44.09%-71K
67.48%-254K
8.33%-11K
450.00%203K
Operating profit
-59.18%-7.3M
36.03%-15.37M
-59.06%-6.22M
56.63%-2.64M
74.17%-1.92M
30.53%-4.59M
10.14%-24.03M
31.57%-3.91M
-33.57%-6.09M
4.20%-7.42M
Net non-operating interest income expense
65.12%-1.56M
-50.86%-10.36M
37.24%5.37M
-12.83%-5.37M
-42.87%-5.87M
-135.13%-4.48M
-18.17%-6.87M
-29.48%3.91M
13.15%-4.76M
-1,021.52%-4.11M
Non-operating interest income
967.20%7.39M
39.33%1.5M
118.30%127K
154.82%502K
54.98%420K
-49.53%692K
-0.92%1.08M
-43.98%-694K
-65.07%197K
--271K
Non-operating interest expense
72.89%8.95M
52.26%11.62M
-11.50%-5.49M
18.47%5.88M
43.62%6.29M
57.90%5.18M
36.67%7.63M
32.99%-4.92M
-17.99%4.96M
2,346.67%4.38M
Total other finance cost
----
-22.08%247K
----
----
----
----
-75.95%317K
----
----
----
Other net income (expense)
-41.98%-9.64M
35.61%-6.79M
Gain on sale of security
----
-96.92%29K
----
----
----
----
216.75%941K
----
----
----
Special income (charges)
----
-25.07%-9.67M
----
----
----
----
20.62%-7.73M
----
----
----
-Less:Restructuring and merger&acquisition
----
106.65%9.51M
----
----
----
----
-52.75%4.6M
----
----
----
-Less:Impairment of capital assets
----
--160K
----
----
----
----
----
----
----
----
-Less:Other special charges
----
----
----
----
----
----
--3.13M
----
----
----
Income before tax
2.26%-8.87M
6.13%-35.38M
-54.57%-10.5M
26.15%-8.02M
32.44%-7.79M
-6.59%-9.07M
12.56%-37.69M
36.63%-6.79M
-8.06%-10.86M
-8.49%-11.53M
Income tax
0
-586.13%-1.86M
-3,375.00%-1.57M
-101.80%-6K
-416K
137K
38,100.00%382K
4,700.00%48K
334K
0
Net income
3.71%-8.87M
11.95%-33.52M
-30.51%-8.93M
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
Net income continuous Operations
3.71%-8.87M
11.95%-33.52M
-30.51%-8.93M
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
Minority interest income
Net income attributable to the parent company
3.71%-8.87M
11.95%-33.52M
-30.51%-8.93M
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.71%-8.87M
11.95%-33.52M
-30.51%-8.93M
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
Basic earnings per share
10.53%-0.17
42.24%-0.67
-21.43%-0.17
60.00%-0.16
66.67%-0.14
38.71%-0.19
30.12%-1.16
64.10%-0.14
-8.11%-0.4
-10.53%-0.42
Diluted earnings per share
10.53%-0.17
42.24%-0.67
-21.43%-0.17
60.00%-0.16
66.67%-0.14
38.71%-0.19
30.12%-1.16
64.10%-0.14
-8.11%-0.4
-10.53%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 12.74%27.39M19.80%107.88M19.43%29.55M17.65%27.43M20.06%26.61M22.48%24.29M28.29%90.05M27.53%24.74M20.50%23.32M32.33%22.16M
Operating revenue 12.74%27.39M19.80%107.88M19.43%29.55M17.65%27.43M20.16%26.59M22.48%24.29M28.29%90.05M27.53%24.74M20.50%23.32M32.95%22.13M
Cost of revenue 22.58%10.77M9.55%38.24M17.74%10.86M5.71%9.56M1.86%9.04M13.09%8.79M32.91%34.91M37.09%9.22M33.03%9.04M31.35%8.87M
Gross profit 7.16%16.61M26.28%69.63M20.43%18.69M25.22%17.88M32.22%17.57M28.53%15.5M25.52%55.14M22.46%15.52M13.72%14.28M32.99%13.29M
Operating expense 19.04%23.92M7.37%85M28.21%24.91M0.74%20.52M-5.90%19.48M7.63%20.09M12.03%79.17M5.66%19.43M19.01%20.37M16.75%20.7M
Selling and administrative expenses 30.98%20.52M8.72%66.75M28.10%16.88M10.35%18.05M-1.93%16.16M1.79%15.66M5.31%61.4M-9.66%13.18M13.25%16.35M9.82%16.48M
-Selling and marketing expense 25.82%12.36M20.66%7.77M9.18%-22.56M-0.29%10.59M-6.69%9.92M-2.06%9.82M-12.53%6.44M-23.78%-24.84M17.21%10.62M14.68%10.63M
-General and administrative expense 39.66%8.16M7.32%58.98M3.75%39.44M30.06%7.46M6.73%6.24M9.01%5.84M7.89%54.95M9.70%38.02M6.58%5.74M1.95%5.84M
Research and development costs -14.61%2.13M-1.91%10.35M17.54%3.28M-25.58%2.01M-11.57%2.57M15.48%2.5M65.50%10.55M52.43%2.79M73.22%2.7M73.42%2.9M
Depreciation amortization depletion -4.31%1.27M8.81%7.93M7.48%3.99M-2.26%1.3M17.54%1.32M17.51%1.32M19.15%7.29M35.03%3.72M17.64%1.33M0.72%1.12M
-Depreciation and amortization -4.31%1.27M8.81%7.93M7.48%3.99M-2.26%1.3M17.54%1.32M17.51%1.32M19.15%7.29M35.03%3.72M17.64%1.33M0.72%1.12M
Other operating expenses -99.67%2K56.34%-31K397.64%756K-7,481.82%-834K-376.35%-561K6,855.56%608K44.09%-71K67.48%-254K8.33%-11K450.00%203K
Operating profit -59.18%-7.3M36.03%-15.37M-59.06%-6.22M56.63%-2.64M74.17%-1.92M30.53%-4.59M10.14%-24.03M31.57%-3.91M-33.57%-6.09M4.20%-7.42M
Net non-operating interest income expense 65.12%-1.56M-50.86%-10.36M37.24%5.37M-12.83%-5.37M-42.87%-5.87M-135.13%-4.48M-18.17%-6.87M-29.48%3.91M13.15%-4.76M-1,021.52%-4.11M
Non-operating interest income 967.20%7.39M39.33%1.5M118.30%127K154.82%502K54.98%420K-49.53%692K-0.92%1.08M-43.98%-694K-65.07%197K--271K
Non-operating interest expense 72.89%8.95M52.26%11.62M-11.50%-5.49M18.47%5.88M43.62%6.29M57.90%5.18M36.67%7.63M32.99%-4.92M-17.99%4.96M2,346.67%4.38M
Total other finance cost -----22.08%247K-----------------75.95%317K------------
Other net income (expense) -41.98%-9.64M35.61%-6.79M
Gain on sale of security -----96.92%29K----------------216.75%941K------------
Special income (charges) -----25.07%-9.67M----------------20.62%-7.73M------------
-Less:Restructuring and merger&acquisition ----106.65%9.51M-----------------52.75%4.6M------------
-Less:Impairment of capital assets ------160K--------------------------------
-Less:Other special charges --------------------------3.13M------------
Income before tax 2.26%-8.87M6.13%-35.38M-54.57%-10.5M26.15%-8.02M32.44%-7.79M-6.59%-9.07M12.56%-37.69M36.63%-6.79M-8.06%-10.86M-8.49%-11.53M
Income tax 0-586.13%-1.86M-3,375.00%-1.57M-101.80%-6K-416K137K38,100.00%382K4,700.00%48K334K0
Net income 3.71%-8.87M11.95%-33.52M-30.51%-8.93M28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M
Net income continuous Operations 3.71%-8.87M11.95%-33.52M-30.51%-8.93M28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M
Minority interest income
Net income attributable to the parent company 3.71%-8.87M11.95%-33.52M-30.51%-8.93M28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.71%-8.87M11.95%-33.52M-30.51%-8.93M28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M
Basic earnings per share 10.53%-0.1742.24%-0.67-21.43%-0.1760.00%-0.1666.67%-0.1438.71%-0.1930.12%-1.1664.10%-0.14-8.11%-0.4-10.53%-0.42
Diluted earnings per share 10.53%-0.1742.24%-0.67-21.43%-0.1760.00%-0.1666.67%-0.1438.71%-0.1930.12%-1.1664.10%-0.14-8.11%-0.4-10.53%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More